Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process

Published:2019-03 Issue:3 Volume:21 Page:307-314
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Hopewell Emily L.,Cox Cheryl,Pilon-Thomas Shari,Kelley Linda L.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference16 articles.

1. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013

2. Adoptive cell transfer for patients with metastatic melanoma: the potential and promise of cancer immunotherapy;Phan;Cancer Control,2013

3. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report;Rosenberg;N Engl J Med,1988

4. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy;Rosenberg;Clin Cancer Res,2011

5. Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma;Pilon-Thomas;J Immunother,2012

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cell manufacturing landscape—Lessons from the past decade and considerations for early clinical development;Molecular Therapy - Methods & Clinical Development;2024-06

2. Lifileucel: First Approval;Molecular Diagnosis & Therapy;2024-04-16

3. Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy;Journal for ImmunoTherapy of Cancer;2024-02

4. AZD1775 and anti-PD-1 antibody synergistically sensitize hepatoma to radiotherapy;Chinese Medical Journal;2024-01-03

5. DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development;International Review of Cell and Molecular Biology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3